← Leaderboards
Yang Hu
Stanford University
$15,136,002
Attributed
$16,165,660
Total exposure
10
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2013–25$5M$3.8M$2.5M$1.3M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,165,660 · 10
By mechanism
R01$14,530,860 · 6
P30$1,310,604 · 3
R21$324,196 · 1
Top collaborators
- Hao F Zhang3 shared
Most similar at Stanford University
Same institution · by research overlap
- Thomas Robert Clandinin$20,437,529
- Mark J Schnitzer$28,784,722
- Sean Crosson$12,220,873
- Irving Lerner Weissman$56,491,773
- Roarke Alexander Kamber$1,997,066
Others in their field
Top investigators on “Neurons”
- Hongkui Zeng · Allen Institute$106,358,289
- Eric Martin McDade · Washington University$94,632,845
- Ed Lein · Allen Institute$90,858,363
- Randall J Bateman · Washington University$65,841,935
- John Morris · Washington University$65,018,684
- Paul S. Aisen · Cognition Therapeutics, Inc.$58,570,460
Research focus
NeuronsIn VivoRetinal Ganglion CellsOptic NerveAxonBlindnessNeuroprotectionExperimental StudyMediatingVisionPreventGlaucomaAxon InjuryNerve DegenerationOptic Nerve InjuriesAxonal DegenerationRetinaMorphologyCellsProteinsSignal TransductionTranslatingMonitorResponse
Grant awards (39)
In Vivo Function and Metabolism Evaluation of Glaucomatous RGCs by Two-Photon Scanning Laser Ophthalmology$746,153
R01 · FY2025 · EY · contact PI
Elucidating Neuron-Intrinsic Molecular Mechanisms of Optic Nerve Regeneration$675,385
R01 · FY2025 · EY · contact PI
Optineurin dysfunction induces neurodegeneration in normal tension glaucoma by a novel molecular mechanism$545,696
R01 · FY2025 · EY · contact PI
Developing ER Stress Chemical Modulators as Neuroprotectants for Glaucoma$502,677
R01 · FY2025 · EY · contact PI
Neurogenetics of Vision Core$263,247
P30 · FY2025 · EY · contact PI
In Vivo Function and Metabolism Evaluation of Glaucomatous RGCs by Two-Photon Scanning Laser Ophthalmology$671,615
R01 · FY2024 · EY · contact PI
Optineurin dysfunction induces neurodegeneration in normal tension glaucoma by a novel molecular mechanism$545,696
R01 · FY2024 · EY · contact PI
Neurogenetics of Vision Core$263,247
P30 · FY2024 · EY · contact PI
In Vivo Function and Metabolism Evaluation of Glaucomatous RGCs by Two-Photon Scanning Laser Ophthalmology$641,549
R01 · FY2023 · EY · contact PI
Optineurin dysfunction induces neurodegeneration in normal tension glaucoma by a novel molecular mechanism$545,696
R01 · FY2023 · EY · contact PI
Elucidating Neuron-Intrinsic Molecular Mechanisms of Optic Nerve Regeneration$435,896
R01 · FY2023 · EY · contact PI
Neurogenetics of Vision Core$263,246
P30 · FY2023 · EY · contact PI
Optineurin dysfunction induces neurodegeneration in normal tension glaucoma by a novel molecular mechanism$545,696
R01 · FY2022 · EY · contact PI
Elucidating Neuron-Intrinsic Molecular Mechanisms of Optic Nerve Regeneration$470,240
R01 · FY2022 · EY · contact PI
Neuroprotection by Modulating ER Stress in Glaucoma$391,989
R01 · FY2022 · EY · contact PI
Neurogenetics of Vision Core$268,362
P30 · FY2022 · EY · contact PI
Elucidating Neuron-Intrinsic Molecular Mechanisms of Optic Nerve Regeneration$465,650
R01 · FY2021 · EY · contact PI
Developing Novel Neuroprotective Strategies for EAE/Optic Neuritis$455,432
R01 · FY2021 · EY · contact PI
Neuroprotection by Modulating ER Stress in Glaucoma$416,615
R01 · FY2021 · EY · contact PI
Neurogenetics of Vision$252,502
P30 · FY2021 · EY · contact PI
Neuroprotection by Modulating ER Stress in Glaucoma$157,400
R01 · FY2021 · EY · contact PI
Elucidating Neuron-Intrinsic Molecular Mechanisms of Optic Nerve Regeneration$475,321
R01 · FY2020 · EY · contact PI
Developing Novel Neuroprotective Strategies for EAE/Optic Neuritis$469,519
R01 · FY2020 · EY · contact PI
Neuroprotection by Modulating ER Stress in Glaucoma$439,500
R01 · FY2020 · EY · contact PI
Developing Novel Neuroprotective Strategies for EAE/Optic Neuritis$483,649
R01 · FY2019 · EY · contact PI
Neuroprotection by Modulating ER Stress in Glaucoma$449,135
R01 · FY2019 · EY · contact PI
Development and Characterization of Silicone Oil-Induced Reversible Ocular Hypertension Glaucoma Model$324,196
R21 · FY2019 · EY · contact PI
Developing Novel Neuroprotective Strategies for EAE/Optic Neuritis$463,710
R01 · FY2018 · EY · contact PI
Elucidating Neuron-Intrinsic Molecular Mechanisms of Optic Nerve Regeneration$379,709
R01 · FY2018 · EY · contact PI
Elucidating Neuron-Intrinsic Molecular Mechanisms of Optic Nerve Regeneration$106,371
R01 · FY2018 · EY · contact PI
Elucidating Neuron-Intrinsic Molecular Mechanisms of Optic Nerve Regeneration$389,302
R01 · FY2017 · EY · contact PI
Neuroprotection by Modulating ER Stress in Glaucoma$360,751
R01 · FY2017 · EY · contact PI
Neuroprotection by Modulating ER Stress in Glaucoma$390,000
R01 · FY2016 · EY · contact PI
Elucidating Neuron-Intrinsic Molecular Mechanisms of Optic Nerve Regeneration$253,844
R01 · FY2016 · EY · contact PI
Elucidating Neuron-Intrinsic Molecular Mechanisms of Optic Nerve Regeneration$126,636
R01 · FY2016 · EY · contact PI
Elucidating Neuron-Intrinsic Molecular Mechanisms of Optic Nerve Regeneration$384,400
R01 · FY2015 · EY · contact PI
Neuroprotection by Modulating ER Stress in Glaucoma$382,200
R01 · FY2015 · EY · contact PI
Neuroprotection by Modulating ER Stress in Glaucoma$375,928
R01 · FY2014 · EY · contact PI
Neuroprotection by Modulating ER Stress in Glaucoma$387,500
R01 · FY2013 · EY · contact PI